What is the current Adhesive Hemostatic Agents market size?

The Adhesive Hemostatic Agents market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Adhesive Hemostatic Agents market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the Adhesive Hemostatic Agents market?

Increasing surgical procedures and advancements in medical technology are key drivers of the market.

What are the challenges facing the Adhesive Hemostatic Agents market?

Stringent regulatory requirements and high production costs are major challenges for market players.

Which regions are leading the Adhesive Hemostatic Agents market?

North America and Europe are regional leaders, accounting for over 60% of the market share.

Who are the top companies in the Adhesive Hemostatic Agents market?

Johnson & Johnson, Medtronic, and Baxter International are top companies, driving market growth.

What future opportunities exist in the Adhesive Hemostatic Agents market?

Emerging economies and increasing demand for minimally invasive surgeries present future opportunities.

How is technology impacting the Adhesive Hemostatic Agents market?

Advances in biomaterials and nanotechnology are improving product efficacy, driving market growth.

What is the current regulatory landscape for Adhesive Hemostatic Agents?

Regulatory bodies like FDA and CE mark are ensuring product safety, influencing market trends.

Adhesive Hemostatic Agents - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Adhesive Hemostatic Agents by Type (Fibrin Sealant, α-Cyanoacrylate, PEG), by Application (Hospital, Clinic, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Adhesive Hemostatic Agents Market Size | CAGR 7.8 Forecast 2033

Adhesive Hemostatic Agents - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Adhesive Hemostatic Agents Market Overview

The Adhesive Hemostatic Agents market refers to the industry that provides medical devices used to control bleeding during surgical procedures. As the Adhesive Hemostatic Agents market size is expected to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a promising future for industry players. The industry expansion is driven by the increasing demand for effective hemostasis in surgical procedures, with the global market projected to grow at a CAGR of 7.5% from 2026 to 2033. The scope of the market encompasses various types of adhesive hemostatic agents, including fibrin sealants, collagen-based agents, and cyanoacrylate-based agents, used in different applications such as surgical procedures, trauma care, and wound care.

Loading chart…

The growth of the Adhesive Hemostatic Agents market is driven by key forces such as technology shifts, with advancements in biomaterials and biotechnology leading to the development of more effective and easy-to-use hemostatic agents. Additionally, regulations and consumer behavior play a crucial role, with increasing demand for minimally invasive surgical procedures and wound care driving the adoption of adhesive hemostatic agents. The largest region for the Adhesive Hemostatic Agents market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing demand for advanced healthcare solutions and the growing presence of key market players. The competitive intensity in the market is high, with major players such as Johnson & Johnson and Baxter International competing for market share.

Report Overview

Report Attribute	Details
Market size value in 2025	8.90 million
Revenue forecast in 2033	16.23 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; Baxter; Harbin Hanbang Medical; Shanghai RAAS; Hualan Biological Engineering; Zhejiang Sealant Pharma; Ethicon (a subsidiary of Johnson & Johnson); C.R. Bard, Inc. (now part of BD); Pfizer Inc.; Medtronic plc
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Adhesive Hemostatic Agents market is poised for significant growth, driven by increasing demand for effective wound closure and hemostasis solutions. The Adhesive Hemostatic Agents market size is expected to expand substantially, with a growth forecast that underscores the potential for innovation and investment in this space.

Growth Drivers2 items

Advances in biomaterials and bioadhesives are enabling the development of more effective Adhesive Hemostatic Agents, driving growth in the market and contributing to an increased Adhesive Hemostatic Agents market size.

Rising surgical procedure volumes, particularly in the areas of cardiovascular and neurosurgery, are fueling demand for Adhesive Hemostatic Agents, supporting the growth forecast for this market.

Restraints2 items

Stringent regulatory requirements and the need for rigorous testing and validation are limiting the pace of innovation in the Adhesive Hemostatic Agents market, potentially impacting the growth forecast.

Concerns around biocompatibility and potential adverse reactions are necessitating careful evaluation and mitigation strategies, affecting the overall Adhesive Hemostatic Agents market size.

Opportunities2 items

The growing trend towards minimally invasive procedures presents opportunities for Adhesive Hemostatic Agents to play a critical role in facilitating these surgeries, contributing to market growth and an increased Adhesive Hemostatic Agents market size.

Emerging nanotechnology and biotechnology advancements hold promise for the development of novel, high-performance Adhesive Hemostatic Agents, supporting the growth forecast for this market.

Challenges2 items

The high development costs associated with bringing new Adhesive Hemostatic Agents to market can be a significant barrier to entry, impacting the Adhesive Hemostatic Agents market size and growth forecast.

Effective supply chain management and distribution strategies are crucial to ensuring the timely and widespread availability of Adhesive Hemostatic Agents, influencing the overall growth of the Adhesive Hemostatic Agents market.

Market Segmentation

Loading chart…

The Adhesive Hemostatic Agents market can be segmented based on Type, which includes various subtypes such as mechanical hemostats, active hemostats, and hemostatic sealants. Each subtype contributes to the overall Adhesive Hemostatic Agents market size, with mechanical hemostats being the largest segment. Understanding the Adhesive Hemostatic Agents segmentation is crucial for market players to develop targeted strategies and capitalize on emerging opportunities.

The Adhesive Hemostatic Agents market can also be segmented based on Application, which includes subtypes such as surgical procedures, trauma cases, and dental procedures. Surgical procedures account for the largest share of the market, driven by the increasing number of surgeries performed globally. Analyzing the market taxonomy, particularly the Adhesive Hemostatic Agents segmentation by application, helps stakeholders to identify high-growth areas and develop effective marketing strategies.

Adhesive Hemostatic Agents Segmentation Breakdown8 items

Type

Fibrin Sealant

α-Cyanoacrylate

PEG

Application

Hospital

Clinic

Other

Regional Insights

Loading chart…

The Adhesive Hemostatic Agents market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market share. The Asia Pacific region is anticipated to be the fastest-growing region, driven by increasing adoption of advanced medical technologies, favorable government policies, and rising investments in healthcare infrastructure.

Key drivers for each region include: for North America, high demand for effective hemostatic agents, well-established healthcare infrastructure, and significant investments in medical research. In Europe, the key drivers are stringent regulatory frameworks, increasing focus on patient safety, and growing adoption of minimally invasive surgical procedures. The Asia Pacific region is driven by large patient populations, rising healthcare expenditures, and growing demand for advanced medical products. Latin America is driven by improving healthcare infrastructure, increasing adoption of new technologies, and government initiatives to enhance healthcare services. The Middle East & Africa region is driven by growing investments in healthcare, rising demand for specialized medical products, and increasing focus on healthcare infrastructure development.

The regional forecast indicates that the Adhesive Hemostatic Agents market will continue to grow, driven by factors such as demographics, ecosystem maturity, and infrastructure development. Understanding the regional dynamics and key drivers is crucial for market players to develop effective strategies and capitalize on emerging opportunities in the Adhesive Hemostatic Agents market.

Competitive Landscape

The Adhesive Hemostatic Agents market exhibits a moderately consolidated structure, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Adhesive Hemostatic Agents competitive landscape is characterized by key competitive levers, including product quality, customer service, and strategic partnerships. Global players tend to dominate the market, while local companies focus on regional expansion and customization to gain a competitive edge.

Companies in the Adhesive Hemostatic Agents market employ various strategies to differentiate themselves, including mergers and acquisitions, partnerships, product launches, and research and development. Common challenges faced by these companies include margin pressure, compliance costs, and supply chain risks. To stay competitive, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have adopted distinct strategies:

Johnson & Johnson: regional expansion

Baxter: innovation pipeline

Harbin Hanbang Medical: local manufacturing

Shanghai RAAS: OEM tie-ups

Hualan Biological Engineering: premium pricing

Zhejiang Sealant Pharma: vertical integration

Key Adhesive Hemostatic Agents Companies10 items

Johnson & Johnson

Baxter

Harbin Hanbang Medical

Shanghai RAAS

Hualan Biological Engineering

Zhejiang Sealant Pharma

Ethicon (a subsidiary of Johnson & Johnson)

C.R. Bard, Inc. (now part of BD)

Pfizer Inc.

Medtronic plc

Market Ecosystem

The Adhesive Hemostatic Agents ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of adhesive hemostatic agents, with each segment influencing the overall efficiency and effectiveness of the ecosystem. A comprehensive value chain analysis is essential to understanding the complex interactions within the Adhesive Hemostatic Agents ecosystem.

Raw material suppliers — providing essential components

OEMs / manufacturers — developing and producing agents

Technology providers — offering innovative solutions

Distributors / channel partners — facilitating market access

Service providers / after-sales — supporting product implementation

End users / buyers — driving demand and adoption

Regulators/standards bodies — establishing industry standards

The flow of value within the Adhesive Hemostatic Agents ecosystem is influenced by various control points, including regulatory approvals, technological advancements, and partnerships between ecosystem participants. Dependency risks, such as input constraints and standards compliance, can impact the efficiency of the ecosystem. Furthermore, switching costs, interoperability requirements, and regional differences in demand and regulatory frameworks can affect the dynamics of the ecosystem, highlighting the need for a nuanced understanding of these factors to navigate the Adhesive Hemostatic Agents ecosystem effectively.

Recent Industry Insights

Recent developments in the Adhesive Hemostatic Agents industry have been driven by a surge in partnerships and mergers & acquisitions. Over the last 12-18 months, key players have focused on expanding their product portfolios and strengthening their market presence. Notable examples include the launch of innovative product/technology launches, such as bioabsorbable hemostatic agents, which have gained significant attention from medical professionals. Furthermore, regulatory changes have also played a crucial role in shaping Adhesive Hemostatic Agents industry trends, with a growing emphasis on patient safety and efficacy. As a result, the industry has witnessed a shift in consumer or enterprise trends, with increased adoption of hemostatic agents in minimally invasive surgical procedures. Additionally, several companies have secured funding rounds or expansions, enabling them to invest in research and development and drive growth in the Adhesive Hemostatic Agents market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Adhesive Hemostatic Agents market outlook. The market exhibits moderate attractiveness, driven by increasing demand for effective wound closure and hemostasis solutions. The competitive intensity is relatively high, with key players focusing on innovative product developments and strategic partnerships. Looking ahead, the long-term outlook appears promising, with the global Adhesive Hemostatic Agents market expected to grow steadily.

The innovation landscape is characterized by ongoing research into advanced biomaterials and bioactive coatings. However, the demand-supply balance may be affected by regulatory changes and fluctuations in raw material prices. Key risk factors include intense competition, pricing pressure, and potential supply chain disruptions. Despite these challenges, the Adhesive Hemostatic Agents market outlook remains favorable, driven by growing demand for minimally invasive surgical procedures and effective wound care solutions.

11 items

1. Executive Summary

2. Adhesive Hemostatic Agents Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Adhesive Hemostatic Agents Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Adhesive Hemostatic Agents Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. Fibrin Sealant

6.1.2. α-Cyanoacrylate

6.1.3. PEG

6.2. Global Adhesive Hemostatic Agents Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. Hospital

6.2.2. Clinic

6.2.3. Other

6.3. Global Adhesive Hemostatic Agents Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Adhesive Hemostatic Agents Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Adhesive Hemostatic Agents Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Adhesive Hemostatic Agents Market Competition by Key Manufacturers

8.1. Global Adhesive Hemostatic Agents Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Adhesive Hemostatic Agents: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Johnson & Johnson

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Baxter

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Harbin Hanbang Medical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Shanghai RAAS

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Hualan Biological Engineering

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Zhejiang Sealant Pharma

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Ethicon (a subsidiary of Johnson & Johnson)

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. C.R. Bard, Inc. (now part of BD)

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Pfizer Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Medtronic plc

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Adhesive Hemostatic Agents Market

Figure 4: Global Adhesive Hemostatic Agents Market: Drivers

Figure 5: Global Adhesive Hemostatic Agents Market: Challenges

Figure 6: Global Adhesive Hemostatic Agents Market: Trends

Figure 7: Global Adhesive Hemostatic Agents Market: Opportunity

Figure 8: Global Adhesive Hemostatic Agents Market: Restraint

Figure 9: Global Adhesive Hemostatic Agents Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Adhesive Hemostatic Agents Market Value (USD Million) By Region

Figure 15: Global Adhesive Hemostatic Agents Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Adhesive Hemostatic Agents Market Value (USD Million) By Region

Figure 23: Global Adhesive Hemostatic Agents Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Adhesive Hemostatic Agents Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Adhesive Hemostatic Agents Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Adhesive Hemostatic Agents Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Adhesive Hemostatic Agents Market Value (USD Million) By Region

Table 10: Global Adhesive Hemostatic Agents Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Adhesive Hemostatic Agents Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Adhesive Hemostatic Agents Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Adhesive Hemostatic Agents Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Johnson & Johnson Basic Information And Sales Area

Table 31: Johnson & Johnson. Products Portfolio

Table 32: Baxter Basic Information And Sales Area

Table 33: Baxter. Products Portfolio

Table 34: Harbin Hanbang Medical Basic Information And Sales Area

Table 35: Harbin Hanbang Medical. Products Portfolio

Table 36: Shanghai RAAS Basic Information And Sales Area

Table 37: Shanghai RAAS. Products Portfolio

Table 38: Hualan Biological Engineering Basic Information And Sales Area

Table 39: Hualan Biological Engineering. Products Portfolio

Table 40: Zhejiang Sealant Pharma Basic Information And Sales Area

Table 41: Zhejiang Sealant Pharma. Products Portfolio

Table 42: Ethicon (a subsidiary of Johnson & Johnson) Basic Information And Sales Area

Table 43: Ethicon (a subsidiary of Johnson & Johnson). Products Portfolio

Table 44: C.R. Bard, Inc. (now part of BD) Basic Information And Sales Area

Table 45: C.R. Bard, Inc. (now part of BD). Products Portfolio

Table 46: Pfizer Inc. Basic Information And Sales Area

Table 47: Pfizer Inc.. Products Portfolio

Table 48: Medtronic plc Basic Information And Sales Area

Table 49: Medtronic plc. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Type

Table 51: Global Market Share (%) By Type (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Adhesive Hemostatic Agents Market Value (USD Million) By Region

Table 55: Global Adhesive Hemostatic Agents Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Type

Table 58: North America Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Type

Table 61: Europe Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Type

Table 67: South America Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Adhesive Hemostatic Agents Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.90 million
Revenue forecast in 2033	16.23 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; Baxter; Harbin Hanbang Medical; Shanghai RAAS; Hualan Biological Engineering; Zhejiang Sealant Pharma; Ethicon (a subsidiary of Johnson & Johnson); C.R. Bard, Inc. (now part of BD); Pfizer Inc.; Medtronic plc
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options